161 related articles for article (PubMed ID: 37326929)
1. Management of Central Diabetes Insipidus in Disabled Children with Diluted Oral Desmopressin Lyophilisate Formulation Administered Through Nasogastric Tube: A Retrospective Case Series.
Korkmaz HA; Arya VB; Gönüllü A; Coşkunol F; Ozkan B
Paediatr Drugs; 2023 Sep; 25(5):595-601. PubMed ID: 37326929
[TBL] [Abstract][Full Text] [Related]
2. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic effect of oral desmopressin lyophilisate formulation in children with central diabetes insipidus.
Korkmaz HA; Coşkunol F; Barışık V; Ozkan B
J Pediatr Endocrinol Metab; 2023 Oct; 36(10):925-929. PubMed ID: 37658767
[TBL] [Abstract][Full Text] [Related]
4. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
5. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
6. Oral DDAVP is a good alternative therapy for patients with central diabetes insipidus: experience of five-year treatment.
Fukuda I; Hizuka N; Takano K
Endocr J; 2003 Aug; 50(4):437-43. PubMed ID: 14599118
[TBL] [Abstract][Full Text] [Related]
7. Central diabetes insipidus: A rare complication of IVH in a very low birth weight preterm infant.
Thakore P; Dunbar AE; Lindsay EB
J Neonatal Perinatal Med; 2019; 12(1):103-107. PubMed ID: 30530977
[TBL] [Abstract][Full Text] [Related]
8. [Case of severe motor and intellectual disabilities presenting with partial central diabetes insipidus triggered by infection].
Serizawa M; Hatakeyama K; Ono C; Kamiya Y; Aihara M; Nakazawa S
No To Hattatsu; 2004 Sep; 36(5):414-8. PubMed ID: 15461031
[TBL] [Abstract][Full Text] [Related]
9. Management of central diabetes insipidus.
Garrahy A; Thompson CJ
Best Pract Res Clin Endocrinol Metab; 2020 Sep; 34(5):101385. PubMed ID: 32169331
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin oral lyophilisate in young children: new insights in pharmacokinetics and pharmacodynamics.
Dossche L; Michelet R; De Bruyne P; Van Herzeele C; Gasthuys E; Rittig S; Vermeulen A; Vande Walle J
Arch Dis Child; 2021 Jun; 106(6):597-602. PubMed ID: 32737054
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia as a clue for central diabetes insipidus (lack of V1 effect) in the differential diagnosis of polydipsia.
Decaux G; Prospert F; Namias B; Soupart A
Am J Med; 1997 Nov; 103(5):376-82. PubMed ID: 9375705
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
14. Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study.
Behan LA; Sherlock M; Moyles P; Renshaw O; Thompson CJ; Orr C; Holte K; Salehmohamed MR; Glynn N; Tormey W; Thompson CJ
Eur J Endocrinol; 2015 Mar; 172(3):243-50. PubMed ID: 25430399
[TBL] [Abstract][Full Text] [Related]
15. Transient Central Diabetes Insipidus Occurring After Vasopressin Infusion.
Cristiano EA; Harris A; Grdinovac K
AACE Clin Case Rep; 2022; 8(1):8-10. PubMed ID: 35097193
[TBL] [Abstract][Full Text] [Related]
16. Severe water intoxication secondary to the concomitant intake of non-steroidal anti-inflammatory drugs and desmopressin: a case report and review of the literature.
Verrua E; Mantovani G; Ferrante E; Noto A; Sala E; Malchiodi E; Iapichino G; Peccoz PB; Spada A
Hormones (Athens); 2013; 12(1):135-41. PubMed ID: 23624139
[TBL] [Abstract][Full Text] [Related]
17. Management of transient central diabetes insipidus with intravenous desmopressin in a premature infant with gastroschisis and septo-optic dysplasia: A case report.
Kim F; Towers HM
J Neonatal Perinatal Med; 2021; 14(2):293-297. PubMed ID: 32804104
[TBL] [Abstract][Full Text] [Related]
18. Unusual ischemic kidney injury presenting as slowly declining graft function and successful use of oral desmopressin in a kidney transplant recipient with subclinical central diabetes insipidus.
Kaneko S; Usui J; Kawanishi K; Ishii R; Takahashi K; Suzuki H; Saito C; Oda T; Nagata M; Yamagata K
Clin Nephrol; 2021 Apr; 95(4):208-214. PubMed ID: 33560220
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series.
Achinger SG; Arieff AI; Kalantar-Zadeh K; Ayus JC
Nephrol Dial Transplant; 2014 Dec; 29(12):2310-5. PubMed ID: 25107337
[TBL] [Abstract][Full Text] [Related]
20. Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency.
Non L; Brito D; Anastasopoulou C
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25612752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]